Trials / Conditions / Microsatellite Instability High

Microsatellite Instability High

11 registered clinical trials studyying Microsatellite Instability High — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer NCT06520683	Sun Yat-sen University	Phase 3
Terminated	Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Can NCT06034860	Molecular Templates, Inc.	Phase 1
Active Not Recruiting	A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectab NCT05572684	NextCure, Inc.	Phase 1 / Phase 2
Completed	Microsatellite Instability in Colorectal Cancers NCT05162248	Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey	—
Active Not Recruiting	PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer NCT04715633	Sun Yat-sen University	Phase 2
Terminated	Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors NCT04116320	Craig L Slingluff, Jr	Phase 1
Withdrawn	Anti-PD-1 +/- RT for MSI-H Solid Tumors NCT04001101	University of Colorado, Denver	Phase 2
Completed	The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival NCT04482608	Sun Yat-sen University	—
Terminated	Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumor NCT04234113	SOTIO Biotech AG	Phase 1
Active Not Recruiting	Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in NCT03836352	ImmunoVaccine Technologies, Inc. (IMV Inc.)	Phase 2